SAO PAULO (Reuters) - Brazilian pharmaceutical company Hypera SA has acquired 12 over-the-counter (OTC) and prescription brands in Latin America from France’s Sanofi SA for $190.3 million, the company said in a securties filing.
Among the brands acquired are mouth wash Cepacol and antipyretic AAS. Hypera is also buying drugs to treat epilepsy. Hypera has recently bought Takeda’s portfolio in Brazil.
Reporting by Paula Laier, editing by Louise Heavens
Our Standards: The Thomson Reuters Trust Principles.